IP Library Granted Patent US 12,357,705
Granted Patent B2
US 12,357,705 · App. 17/291,908 · Granted Jul 15, 2025

Negatively charged peg-lipid conjugates

Inventors: James Heyes (Vancouver, CA); Kieu Mong Lam (Richmond, CA); Mark Wood (Port Moody, CA)
Assignee: ARBUTUS BIOPHARMA CORPORATION
A61K48/0033A61K9/1617A61K31/7105A61K47/543A61K47/60
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,357,705
App. No.
17/291,908
Granted
Jul 15, 2025
Kind
B2
Abstract

The invention provides PEG-conjugated lipids of formula (I): A-B-C (I) wherein A, B, and C have any of the values defined in the specification, as well as compositions comprising the PEG-conjugated lipids of formula (I), nucleic acid lipid nanoparticles comprising the PEG-conjugated lipids of formula (I), and methods of using the PEG-conjugated lipids of formula (I), the compositions, and the nucleic acid nanoparticles.

Claims (35)

1. A compound of formula (I):

A-B-C  (I)

wherein:

A is (C 1 -C 6 )alkyl, (C 3 -C 8 )cycloalkyl, (C 3 -C 8 )cycloalkyl(C 1 -C 6 )alkyl, (C 1 -C 6 )alkoxy, (C 2 -C 6 )alkenyl, (C 2 -C 6 )alkynyl, (C 1 -C 6 )alkanoyl, (C 1 -C 6 )alkoxycarbonyl, (C 1 -C 6 )alkylthio, or (C 2 -C 6 )alkanoyloxy, wherein any (C 1 -C 6 )alkyl, (C 3 -C 8 )cycloalkyl, (C 3 -C 8 )cycloalkyl(C 1 -C 6 )alkyl, (C 1 -C 6 )alkoxy, (C 2 -C 6 )alkenyl, (C 2 -C 6 )alkynyl, (C 1 -C 6 )alkanoyl, (C 1 -C 6 )alkoxycarbonyl, (C 1 -C 6 )alkylthio, and (C 2 -C 6 )alkanoyloxy is substituted with one or more anionic precursor groups, and wherein any (C 1 -C 6 )alkyl, (C 3 -C 8 )cycloalkyl, (C 3 -C 8 )cycloalkyl(C 1 -C 6 )alkyl, C 1 -C 6 )alkoxy, (C 2 -C 6 )alkenyl, (C 2 -C 6 )alkynyl, (C 1 -C 6 )alkanoyl, (C 1 -C 6 )alkoxycarbonyl, (C 1 -C 6 )alkylthio, and (C 2 -C 6 )alkanoyloxy is optionally substituted with one or more groups independently selected from the group consisting of halo, hydroxyl, (C 1 -C 3 )alkoxy, (C 1 -C 6 )alkanoyl, (C 1 -C 3 )alkoxycarbonyl, (C 1 -C 3 )alkylthio, and(C 2 -C 3 )alkanoyloxy;

each anionic precursor group is capable of forming an anion at physiological pH;

A is linked to B directly or via a linker moiety selected from the group consisting of —C(O)NR b —, —NR b —, —C(O)—, —NR b C(O)O—, —NR b C(O)NR b —, —S—S—, —O—, —(O)CCH 2 CH 2 C(O)—, and —NHC(O)CH 2 CH 2 C(O)NH—;

B is a polyethylene glycol chain having a molecular weight of from about 550 daltons to about 10,000 daltons;

C is -L-R a

L is selected from the group consisting of a direct bond, —C(O)O—, —C(O)NR b —, —NR b —, —C(O)—, —NR b C(O)O—, —NR b C(O)NR b —, —S—S—, —O—, —(O)CCH 2 CH 2 C(O)—, and —NHC(O)CH 2 CH 2 C(O)NH—;

R a is a branched (C 10 -C 50 )alkyl or branched (C 10 -C 50 )alkenyl wherein one or more carbon atoms of the branched (C 10 -C 50 )alkyl or branched (C 10 -C 50 )alkenyl have been replaced with —O—; and

each R b is independently H or (C 1 -C 6 )alkyl.

2. The compound of claim 1 , wherein A is (C 1 -C 6 )alkyl, (C 3 -C 8 )cycloalkyl, (C 2 -C 6 )alkenyl, or (C 2 -C 6 )alkynyl, wherein any (C 1 -C 6 )alkyl, (C 3 -C 8 )cycloalkyl, (C 2 -C 6 )alkenyl, and (C 2 -C 6 )alkynyl is substituted with one or more anionic precursor groups, and wherein any (C 1 -C 6 )alkyl, (C 3 -C 8 )cycloalkyl, (C 2 -C 6 )alkenyl, and (C 2 -C 6 )alkynyl is optionally substituted with one or more groups independently selected from the group consisting of halo, hydroxyl, (C 1 -C 3 )alkoxy, (C 1 -C 6 )alkanoyl, (C 1 -C 3 )alkoxycarbonyl, (C 1 -C 3 )alkylthio, and (C 2 -C 3 )alkanoyloxy.

3. The compound of claim 1 , wherein A is (C 1 -C 6 )alkyl, (C 3 -C 8 )cycloalkyl, (C 2 -C 6 )alkenyl, or (C 2 -C 6 )alkynyl, wherein any (C 1 -C 6 )alkyl, (C 3 -C 8 )cycloalkyl, (C 2 -C 6 )alkenyl, and (C 2 -C 6 )alkynyl is substituted with one or more anionic precursor groups, and wherein any (C 1 -C 6 )alkyl, (C 3 -C 8 )cycloalkyl, (C 2 -C 6 )alkenyl, and (C 2 -C 6 )alkynyl is not further substituted with one or more additional groups.

4. The compound of claim 1 , wherein A is (C 1 -C 6 )alkyl that is substituted with one or more anionic precursor groups, and is optionally substituted with one or more groups independently selected from the group consisting of halo, hydroxyl, (C 1 -C 3 )alkoxy, (C 1 -C 6 )alkanoyl, (C 1 -C 3 )alkoxycarbonyl, (C 1 -C 3 )alkylthio, and(C 2 -C 3 )alkanoyloxy.

5. The compound of claim 1 , wherein each anionic precursor group is —CO 2 H.

6. The compound of claim 1 , wherein B is a polyethylene glycol chain having an average molecular weight range of about 2,000 daltons.

7. The compound of claim 1 , wherein A is linked to B via the linker moiety.

8. The compound of claim 1 , wherein L is —NR b —.

9. The compound of claim 1 , wherein C has the following structure:

wherein:

R 1 and R 2 are each independently (C 10 -C 20 )alkyl or (C 10 -C 20 )alkenyl;

M is a direct bond or a divalent (C 1 -C 5 )alkyl;

L is selected from the group consisting of a direct bond, —C(O)O—, —C(O)NR b —, —NR b —, —C(O)—, —NR b C(O)—, —NR b C(O)NR b —, —S—S—, —O—, —(O)CCH 2 CH 2 C(O)—, and —NHC(O)CH 2 CH 2 C(O)NH—; and

each R b is independently H or (C 1 -C 6 )alkyl.

10. The compound of claim 1 , wherein A is substituted with one anionic precursor group.

11. The compound of claim 1 , wherein A is substituted with three anionic precursor groups.

12. The compound of claim 1 , wherein each anionic precursor group is selected from the group consisting of —CO 2 H, —O—P(═O)(OH) 2 , —OS(═O) 2 (OH), —O—S(═O)(OH), and —B(OH) 2 .

13. The compound of claim 1 , wherein A is linked to B directly.

14. The compound of claim 1 , wherein L is —C(O)NR b —, —NR b —, —C(O)—, —NR b C(O)O—, —NR b C(O)NR b —, —S—S—, —O—, —(O)CCH 2 CH 2 C(O)—, or —NHC(O)CH 2 CH 2 C(O)NH—.

15. The compound of claim 1 , wherein R a is a branched (C 10 -C 50 )alkyl or branched (C 10 -C 50 )alkenyl, wherein two carbon atoms of the branched (C 10 -C 50 )alkyl or branched (C 10 -C 50 )alkenyl have been replaced with —O—.

16. The compound of claim 1 , wherein each R b is independently H.

17. The compound of claim 1 , wherein L is —NR b C(O)O—.

18. The compound of claim 9 , wherein M is a direct bond.

19. The compound of claim 9 , wherein at least one of R 1 or R 2 is lauryl (C12), myristyl (C14), palmityl (C16), stearyl (C18), or icosyl (C20).

20. The compound of claim 9 , wherein each R 1 and R 2 are the same.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 2, 2021
From: HEYES, JAMES; LAM, KIEU MONG; WOOD, MARK
To: ARBUTUS BIOPHARMA CORPORATION
Reel/Frame 056412/0141 →
Continuity (2)
Provisional Application 62758099 · Nov 9, 2018
Related Publication 20220072154A1 · Mar 10, 2022
References Cited (29)
US 6417009B1 · Raguse · 2002 [cited by examiner]
US 7803397B2 · Heyes et al. · 2010 [cited by applicant]
US 7982027B2 · MacLachlan et al. · 2011 [cited by applicant]
US 8058069B2 · Yaworski et al. · 2011 [cited by applicant]
US 8492359B2 · Yaworski et al. · 2013 [cited by applicant]
US 8642076B2 · Manoharan et al. · 2014 [cited by applicant]
US 8822668B2 · Yaworski et al. · 2014 [cited by applicant]
US 9006417B2 · Yaworski et al. · 2015 [cited by applicant]
US 9364435B2 · Yaworski et al. · 2016 [cited by applicant]
US 9404127B2 · Yaworski et al. · 2016 [cited by applicant]
US 9504651B2 · MacLachlan et al. · 2016 [cited by applicant]
US 9518272B2 · Yaworski et al. · 2016 [cited by applicant]
US 11141378B2 · Yaworski et al. · 2021 [cited by applicant]
US 11420931B2 · Manoharan et al. · 2022 [cited by applicant]
US 20050064595A1 · MacLachlan et al. · 2005 [cited by applicant]
US 20050175682A1 · Heyes et al. · 2005 [cited by applicant]
US 20060008910A1 · MacLachlan et al. · 2006 [cited by applicant]
US 20060240554A1 · Chen et al. · 2006 [cited by applicant]
US 20090023673A1 · Manoharan · 2009 [cited by examiner]
US 20140134260A1 · Heyes · 2014 [cited by examiner]
WO 2007051303A1 · 2007 [cited by applicant]
WO 2008042973A2 · 2008 [cited by applicant]
WO WO2018165257A1 · 2018 [cited by examiner]
WO 2021030701A1 · 2021 [cited by applicant]
“Precursor” Cambridge Dictionary. Downloaded from https://dictionary.cambridge.org/us/dictionary/english/precursor#google_vignette on Dec. 9, 2024 (Year: 2024). [cited by examiner]
Hydride (‘hydron’ in IUPAC Compendium of Chemical Terminology, 3rd ed. International Union of Pure and Applied Chemistry; 2006. Online version 3.0.1, 2019. https://doi.org/10.1351/goldbook.H02904, downloaded on Dec. 9, … [cited by examiner]
Folic Acid (https://pubchem.ncbi.nlm.nih.gov/compound/Folic-Acid#section=2D-Structure&fullscreen=true, downloaded on Dec. 9, 2024). (Year: 2024). [cited by examiner]
Patent Cooperation Treaty , International Search Report and Written Opinion for PCT/US2019/060518, 12 pages, dated Mar. 4, 2020. [cited by applicant]
Wakefield, D , et al., “Membrane Activity and Transfection Ability of Amphipathic Polycations as a Function of Alkyl Group Size”, Bioconjugate Chem 16, 1204-1208 (2005). [cited by applicant]